pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 11·1 min read
save

Open-access fees rise to $12,850 for NIH-funded study in Nature Medicine

Jun 11, 2026·read at STAT ↗Negative

In 2025 a randomized clinical trial led by Elizabeth Selvin was published in Nature Medicine without any publication charge. The paper underwent peer review and editorial processing at no cost to the authors.

A year later, the same journal required a $12,850 open-access fee for another NIH-funded study to meet the 2024 NIH Public Access Policy that took effect on July 1, 2025. The fee was described as non-negotiable.

Selvin argues that research funded by taxpayers should be freely available and warns that steep open-access fees create barriers to public access.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850”

read at STAT ↗
1,383 words · retrieved Jun 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Johns Hopkins UniversityLEADINGNational Institutes of Health
topics
Type 2 Diabetes6Oncology

related stories

  • Apr 28Opinion: Why do discussions about ‘brain health’ ignore mental illness?STAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 20Opinion: STAT readers debate blue zones, open-access publishing fees, and moreSTAT
  • Jun 12Chile offers new data on food warning label efficacySTAT
  • Jun 11Study highlights influence of socioeconomic status on children’s brain developmentSTAT